DL-Aspartic acid potassium salt

CAS14434-35-6

DL-Aspartic acid potassium salt (CAS 14434-35-6, C4H6KNO4) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.

Chemical structure of DL-Aspartic acid potassium salt
C4H6KNO4 · 171.19 g/mol
CAS No.
14434-35-6
Formula
C4H6KNO4
Mol. weight
171.19 g/mol
Appearance
white powder

Chemical Specifications

Identifiers

CAS number 14434-35-6
Product name DL-Aspartic acid potassium salt
Chinese name DL-天门冬氨酸钾
Synonyms POTASSIUM DL-ASPARTATE
Chinese synonyms DL-天门冬氨酸钾; DL-天门冬氨酸钾盐; DL-天冬氨酸 钾盐
Molecular formula C4H6KNO4
Molecular weight 171.19 g/mol
EC number 213-088-2

Physical and chemical properties

Appearance white powder

Packaging, Storage & Transport

Available pack sizes 5kg, 1kg, 500g, 100g, 50g, 10g

Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.

Frequently Asked Questions

What is the CAS number of DL-Aspartic acid potassium salt?

The CAS Registry Number of DL-Aspartic acid potassium salt is 14434-35-6. DL-Aspartic acid potassium salt is also known as POTASSIUM DL-ASPARTATE.

What is the molecular formula and molecular weight of DL-Aspartic acid potassium salt?

The molecular formula of DL-Aspartic acid potassium salt is C4H6KNO4, and its molecular weight is 171.19 g/mol.

How can I request a quotation for DL-Aspartic acid potassium salt?

Send an inquiry for DL-Aspartic acid potassium salt (CAS 14434-35-6) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.

Request a Quote for DL-Aspartic acid potassium salt

Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.

Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.